Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00914199Not ApplicableCompleted

The Nordic Bifurcation Study III

Role: lead

NCT01496638Not ApplicableActive Not Recruiting

The Nordic-Baltic Bifurcation Study IV

Role: lead

NCT01496651Not ApplicableActive Not Recruiting

PCI vs. CABG in the Treatment of Unprotected Left Main Stenosis

Role: lead

NCT00660478Phase 3Completed

Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients

Role: lead

All 4 trials loaded